Usages in wwPDB of concept: c_0405
nUsages: 579; SSE string: EEEEEEE
4grl:A   (PRO102) to   (PRO180)  CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX  |   IMMUNE COMPLEX, PEPTIDE ANTIGEN PRESENTATION, MULTIPLE SCLEROSIS, AUTOIMMUNITY, IMMUNE SYSTEM 
4grl:B   (ASN113) to   (ARG189)  CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX  |   IMMUNE COMPLEX, PEPTIDE ANTIGEN PRESENTATION, MULTIPLE SCLEROSIS, AUTOIMMUNITY, IMMUNE SYSTEM 
3rol:B    (LEU23) to    (TYR94)  MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH POST-TRANSLATIONALLY MODIFIED LCMV-DERIVED GP34-41 PEPTIDE, COMPRISING A NITROTYROSINE AT POSITION 3  |   T-CELL RECEPTOR, MHC, GP34, NY-GP34, EPITOPE, POST-TRANSLATIONAL MODIFICATION, LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM, T CELL RECOGNITION, AUTOIMMUNITY, T CELL RECEPTOR, NITRO-TYROSINE, CELL SURFACE 
3rol:D    (LEU23) to    (TYR94)  MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH POST-TRANSLATIONALLY MODIFIED LCMV-DERIVED GP34-41 PEPTIDE, COMPRISING A NITROTYROSINE AT POSITION 3  |   T-CELL RECEPTOR, MHC, GP34, NY-GP34, EPITOPE, POST-TRANSLATIONAL MODIFICATION, LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM, T CELL RECOGNITION, AUTOIMMUNITY, T CELL RECEPTOR, NITRO-TYROSINE, CELL SURFACE 
4wht:A   (SER133) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:C   (SER133) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:G   (SER133) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:I   (SER133) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:K   (MET134) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:M   (MET134) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:O   (SER133) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:S   (MET134) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:U   (MET134) to   (PRO211)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:X   (SER133) to   (VAL210)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wi9:A   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi9:B   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi4:A   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi4:B   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi5:A   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi5:B   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi7:B   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi8:A   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
1ahw:B   (SER138) to   (LYS212)  A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)  |   BLOOD COAGULATION, TISSUE FACTOR, FAB, COMPLEX, ANTIBODY, COMPLEX (IMMUNOGLOBULIN/TISSUE FACTOR) 
3rwg:B    (LEU23) to    (LYS94)  RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MW9  |   ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM 
3rwj:B    (LEU23) to    (LYS94)  RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-HW8  |   ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM 
2ox5:C    (GLU18) to   (ALA106)  THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH FOLD, TRANSPORT PROTEIN 
2ox5:E    (GLU18) to   (ALA108)  THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH FOLD, TRANSPORT PROTEIN 
2oxg:A    (GLU18) to   (ALA108)  THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH FOLD, TRANSPORT PROTEIN 
2oxg:C    (GLU18) to   (ALA106)  THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH FOLD, TRANSPORT PROTEIN 
2oxg:E    (GLU18) to   (ALA108)  THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH FOLD, TRANSPORT PROTEIN 
2oxh:Z    (GLU18) to   (ALA106)  THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH FOLD, TRANSPORT PROTEIN 
2oxh:C    (GLU18) to   (ASP101)  THE SOXYZ COMPLEX OF PARACOCCUS PANTOTROPHUS  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH FOLD, TRANSPORT PROTEIN 
4haf:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1b0g:B    (LEU23) to    (LYS94)  CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX  |   CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN 
1b0g:E    (LEU23) to    (LYS94)  CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX  |   CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN 
4hc1:B   (GLU109) to   (PRO200)  CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3  |   IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM 
4ww2:C   (GLY200) to   (TRP277)  CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8, BETA CHAIN- TRBV7-8, ANTIGEN-PRESENTING GLYCOPROTEIN CD1D, AND BETA-2- MICROGLOBULIN  |   NATURAL KILLER T CELLS, IMMUNITY, IMMUNE SYSTEM 
1b3j:A   (ASN197) to   (PRO271)  STRUCTURE OF THE MHC CLASS I HOMOLOG MIC-A, A GAMMADELTA T CELL LIGAND  |   HC I HOMOLOG, HUMAN MICA, MICA, IMMUNOLOGY, MHC, GAMMA-DELTA-TCR, GLYCOPROTEIN, SIGNA IMMUNOGLOBULIN FOLD, T-CELL, IMMUNE SYSTEM 
3es6:A   (LYS201) to   (TRP275)  CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PROTEIN-PROTEIN COMPLEX, PROLACTIN INDUCIBLE PROTEIN, ZINC 2-GLYCOPROTEIN, ZAG-PIP COMPLEX, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ACTIN-BINDING, CELL ADHESION 
2p8l:B   (THR135) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN  |   NMAB 2F5, HIV-1, GP41 EPITOPE, VIRAL PROTEIN 
1bii:B   (PRO320) to   (TYR394)  THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110  |   COMPLEX (MHC I/PEPTIDE), MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I DD, TRANSMEMBRANE, GLYCOPROTEIN 
2boc:A   (MET140) to   (LYS214)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)  |   IMMUNE SYSTEM/TRANSPORT PROTEIN, COMPLEX (ANTIBODY/ION CHANNEL), POTASSIUM CHANNEL, ION TRANSPORT, IONIC CHANNEL, PROTEIN- ANTIBODY FAB COMPLEX 
1bql:H   (SER137) to   (PRO215)  STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME  |   ANTIBODY/ANTIGEN COMPLEX, HYHEL-5, ANTI-LYSOZYME, BOBWHITE QUAIL 
4x6c:A   (GLY200) to   (GLU278)  CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR  |   CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM 
4x6d:A   (GLY200) to   (TRP277)  CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR  |   CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM 
4x6e:A   (GLY200) to   (TYR276)  CD1A BINARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE  |   CD1A, IMMUNE COMPLEX, LIPID ANTIGEN, TCR, IMMUNE SYSTEM 
4huu:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB-NPM6I  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
4huu:E    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB-NPM6I  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
4huw:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB-NPM6T  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
4huw:D    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB-NPM6T  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
4huw:F    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB-NPM6T  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
4huw:H    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB-NPM6T  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
4hv8:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I  |   VIRAL IMMUNITY, T CELL, H2DB, INFLUENZA, VIRAL ESCAPE, IMMUNE SYSTEM 
3sdx:C   (LEU202) to   (TRP277)  CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE  |   CD1D, AUTOIMMUNITY, SELF-RECOGNITION, NKT, EXTRACELLULAR, IMMUNE SYSTEM 
1ogt:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM/COMPLEX, IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705 
4i0k:A   (ASN159) to   (THR238)  CRYSTAL STRUCTURE OF MURINE B7-H3 EXTRACELLULAR DOMAIN  |   IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN, IMMUNITY, ADAPTIVE IMMUNITY, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, IMMUNOGLOBULIN VARIABLE LIKE DOMAIN, IMMUNOGLOBULIN CONSTANT LIKE DOMAIN, CELL SURFACE, PSI-BIOLOGY, IMMUNE SYSTEM 
4i0p:A   (PRO116) to   (PRO193)  HLA-DO IN COMPLEX WITH HLA-DM  |   HLA-DM, HLA-DO, HLA-DR, PEPTIDE LOADING, IMMUNE SYSTEM, INHIBITOR, ENZYME HLA-DM 
4i0p:B   (PRO112) to   (PRO191)  HLA-DO IN COMPLEX WITH HLA-DM  |   HLA-DM, HLA-DO, HLA-DR, PEPTIDE LOADING, IMMUNE SYSTEM, INHIBITOR, ENZYME HLA-DM 
4i0p:E   (PRO116) to   (PRO193)  HLA-DO IN COMPLEX WITH HLA-DM  |   HLA-DM, HLA-DO, HLA-DR, PEPTIDE LOADING, IMMUNE SYSTEM, INHIBITOR, ENZYME HLA-DM 
4i0p:F   (PRO112) to   (PRO191)  HLA-DO IN COMPLEX WITH HLA-DM  |   HLA-DM, HLA-DO, HLA-DR, PEPTIDE LOADING, IMMUNE SYSTEM, INHIBITOR, ENZYME HLA-DM 
3sgj:B   (ASN361) to   (LEU443)  UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3sgk:A   (ASN361) to   (LEU443)  UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE  |   FC RECEPTOR, ANTIBODY, AFUCOSYLATION, IMMUNE SYSTEM 
3sgk:B   (ASN361) to   (LEU443)  UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE  |   FC RECEPTOR, ANTIBODY, AFUCOSYLATION, IMMUNE SYSTEM 
4i2x:E   (VAL136) to   (PRO224)  CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117  |   PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM 
4i2x:F   (HIS134) to   (GLN231)  CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117  |   PROTEIN-FAB COMPLEX, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, SIGNAL REGULATORY PROTEIN, CD47, CELL SURFACE, IMMUNE SYSTEM 
3sko:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF THE HLA-B8-A66-FLR, MUTANT A66 OF THE HLA B8  |   T CELL RECEPTOR, IMMUNE SYSTEM, ANTIGEN PRESENTATION 
1cg9:B    (LEU24) to    (LYS95)  COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6  |   MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/ PEPTIDE), SFR8-B6 EPITOPE 
1onq:C   (GLY200) to   (TRP277)  CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE  |   PROTEIN-GLYCOLIPID COMPLEX, BETA SHEET PLATFORM,, IMMUNE SYSTEM 
3fol:B    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFERI  |   CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, CHROMOSOMAL PROTEIN, DNA-BINDING, METHYLATION, NUCLEOSOME CORE, NUCLEUS, PHOSPHOPROTEIN, IMMUNE SYSTEM 
3fon:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI  |   CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM 
3fon:D    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI  |   CLASS I MHC, PEPTIDE COMPLEX, DIABETES-PROTECTIVE EFFECT, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, SECRETED, IMMUNE SYSTEM 
1oqo:B   (ASN361) to   (LEU443)  COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z  |   ANTIBODY, GLYCOSYLATION, OLIGOSACCHARIDES, IGG, FC FRAGMENT, Z34C, PROTEIN A, IMMUNE SYSTEM 
1osz:B    (PRO20) to    (TYR94)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   MHC/PEPTIDE COMPLEX, TRANSMEMBRANE PROTEIN, THYMIC SELECTION, COMPLEX (MHC I/PEPTIDE) 
3ft2:B    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA- A2  |   HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM 
3ftg:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H2DB IN COMPLEX WITH NP366-N3A VARIANT PEPTIDE FROM INFLUENZA  |   H2DB, MOUSE MHC, INFLUENZA, IMMUNOLOGY, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
1cu4:H   (SER132) to   (PRO209)  CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2q7y:C   (HIS203) to   (TRP279)  STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D  |   ANTIGEN PRESENTING MOLECULE, MHC FOLD, NKT CELLS, IMMUNE SYSTEM 
4xnq:H   (GLY144) to   (LEU223)  ANTIBODY HEMAGGLUTININ COMPLEXES  |   ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4iiq:C    (LEU23) to    (ARG96)  CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1  |   MHC-CLASS I, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, ANTIGEN PRESENTATION, ANTIGEN RECOGNITION, CELL MEMBRANE 
1dbm:H   (SER136) to   (PRO227)  MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY  |   IMMUNOGLOBULIN 
3t1f:A   (GLY202) to   (TRP279)  CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
1dn2:A   (ASN361) to   (LEU443)  FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2  |   FC IGG PHAGE DISPLAY PEPTIDE, IMMUNE SYSTEM 
1dn2:B   (ASN361) to   (SER442)  FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2  |   FC IGG PHAGE DISPLAY PEPTIDE, IMMUNE SYSTEM 
1plg:H   (SER139) to   (LYS212)  EVIDENCE FOR THE EXTENDED HELICAL NATURE OF POLYSACCHARIDE EPITOPES. THE 2.8 ANGSTROMS RESOLUTION STRUCTURE AND THERMODYNAMICS OF LIGAND BINDING OF AN ANTIGEN BINDING FRAGMENT SPECIFIC FOR ALPHA-(2->8)- POLYSIALIC ACID  |   IMMUNOGLOBULIN 
3ghb:H   (GLY134) to   (LEU213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020  |   HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM 
3ghb:I   (GLY134) to   (LEU213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020  |   HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM 
1duy:D   (HIS197) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2d31:E    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER  |   MHC CLASS I, IMMUNE SYSTEM/CELL CYCLE COMPLEX 
3gmr:A   (GLY202) to   (TRP279)  STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP  |   CD1, NKT CELL, GLYCOLIPID, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
4j12:A   (ASN361) to   (LEU443)  MONOMERIC FC  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1e4k:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX  |   IMMUNE SYSTEM, FC FRAGMENT, IGG, RECEPTOR, 
3tbv:B    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G,V3P,Y4A)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbv:H    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G,V3P,Y4A)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbw:B    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbw:D    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbw:F    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
3tbw:H    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, ANTIGEN PRESENTATION, ALTERED PEPTIDE LIGAND, AGONISM, ANTAGONISM, T CELL RECEPTOR, CD8, CELL SURFACE, IMMUNE SYSTEM-AGONIST COMPLEX 
1q1j:H   (GLY136) to   (LEU227)  CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE  |   FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM 
1q1j:I   (GLY136) to   (LEU227)  CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE  |   FAB-PEPTIDE COMPLEX, HIV-1, GP120, V3 LOOP, IMMUNE SYSTEM 
1ed3:B    (LEU23) to    (THR94)  CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.  |   MAJOR HISTOCOMPATIBILITY COMPLEX, RAT MINOR HISTOCOMPATIBILITY COMPLEX, MHC, IMMUNOLOGY, PEPTIDE ANTIGEN PRESENTATION, CELLULAR IMMUNITY, CELL SURFACE RECEPTOR, T CELL RECEPTOR LIGAND, IMMUNE SYSTEM 
1q94:E    (LEU23) to    (ASP98)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
4jff:A   (HIS197) to   (TRP274)  PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR  |   HLA, TCR, MELANOMA MOTIF, IMMUNE SYSTEM, HIGH AFFINITY 
4jfq:B    (SER20) to    (LYS94)  A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
2dts:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1  |   IMMUNOGLOBULIN, IGG1, DEFUCOSYLATED GLYCOFORM, IMMUNE SYSTEM 
2dts:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1  |   IMMUNOGLOBULIN, IGG1, DEFUCOSYLATED GLYCOFORM, IMMUNE SYSTEM 
2rgs:A   (LYS361) to   (SER442)  FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS  |   FC-FRAGMENT, IMMUNOGLOBULIN, GLYCOSYLATION, IMMUNE SYSTEM 
4yfl:F   (GLY134) to   (LYS214)  CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 1B2530 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120  |   HIV-1 CD4 BINDING SITE, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
4jo3:H   (ALA134) to   (PRO210)  CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120  |   IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
1exu:B    (SER20) to    (ARG97)  CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR  |   IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM 
2seb:A   (PRO102) to   (PHE180)  X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II  |   COMPLEX (MHC CLASS II-SUPERANTIGEN), COMPLEX (MHC CLASS II- SUPERANTIGEN) COMPLEX 
1qo3:B    (LEU23) to    (TYR94)  COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD  |   RECEPTOR/IMMUNE SYSTEM, COMPLEX (NK RECEPTOR/MHC CLASS I), NK CELL, INHIBITORY RECEPTOR, MHC-I, C-TYPE LECTIN-LIKE, HISTOCOMPATIBILITY, B2M, LY49, LY-49 
3tzv:C   (LEU203) to   (TYR277)  CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE  |   IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN RECOGNITION, CD1D, CELL SURFACE, IMMUNE SYSTEM 
1qvo:B    (SER20) to    (LYS94)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
3u30:E   (THR129) to   (PHE209)  CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN  |   IMMUNE SYSTEM 
4jvu:B   (LEU255) to   (SER335)  IGM C2-DOMAIN FROM MOUSE  |   IMMUNOGLOBULIN M, ANTIBODY, OLIGOMERIZATION, IMMUNOGLOBULIN FOLD, RECEPTOR, PROTEIN BINDING 
3hcv:B    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA-B*2709, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, DISULFIDE BOND, MHC I 
1fc1:A   (ASN361) to   (SER440)  CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
1fcc:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG  |   COMPLEX (ANTIBODY/ANTIGEN) 
1fcc:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG  |   COMPLEX (ANTIBODY/ANTIGEN) 
1r3h:D  (SER4020) to  (LYS4094)  CRYSTAL STRUCTURE OF T10  |   CLASS IB MHC, GAMMADELTA T CELL LIGAND, IMMUNE SYSTEM 
1ffn:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX 
1ffn:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX 
1ffp:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX 
1ffp:E    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, T CELL RECEPTOR, CRYSTALLOGRAPHY, IMMUNE SYSTEM/SIGNALING PROTEIN COMPLEX 
1r5v:A   (PRO102) to   (PHE180)  EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION  |   TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN 
1r5v:C   (PRO102) to   (PHE180)  EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION  |   TCR, MHC CLASS II, STRUCTURAL REARANGEMENT, SIGNALING PROTEIN 
4k3e:H   (SER134) to   (PRO212)  CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3  |   IMMUNOGLOBULIN; CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM 
4k3e:I   (SER134) to   (PRO212)  CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3  |   IMMUNOGLOBULIN; CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM 
1fne:A   (PRO102) to   (PHE180)  HISTOCOMPATIBILITY ANTIGEN  |   HISTOCOMPATIBILITY ANTIGEN, MHC, IMMUNE SYSTEM 
1fng:A   (PRO102) to   (PHE180)  HISTOCOMPATIBILITY ANTIGEN  |   HISTOCOMPATIBILITY ANTIGEN, MHC, IMMUNE SYSTEM 
2vaa:B    (PRO20) to    (TYR94)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, MHC-PEPTIDE COMPLEX, COMPLEX (MHC I/PEPTIDE) COMPLEX 
2vab:B    (PRO20) to    (TYR94)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN  |   HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, MHC-PEPTIDE COMPLEX, COMPLEX (MHC I/PEPTIDE) COMPLEX 
1rk1:B    (PRO20) to    (TYR94)  MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE  |   MHC, CLASS I, VIRUS, TCR, HERPES, IMMUNE SYSTEM 
1fzj:B    (PRO20) to    (TYR94)  MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
1fzk:B    (PRO20) to    (TYR94)  MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
1fzm:B    (PRO20) to    (TYR94)  MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
2f8v:C    (SER21) to    (ALA93)  STRUCTURE OF FULL LENGTH TELETHONIN IN COMPLEX WITH THE N-TERMINUS OF TITIN  |   SARCOMERE, TITIN, Z1Z2, TELETHONIN, CONTRACTILE PROTEIN-CONTRACTILE PROTEIN COMPLEX 
2f8v:D    (SER21) to    (ALA93)  STRUCTURE OF FULL LENGTH TELETHONIN IN COMPLEX WITH THE N-TERMINUS OF TITIN  |   SARCOMERE, TITIN, Z1Z2, TELETHONIN, CONTRACTILE PROTEIN-CONTRACTILE PROTEIN COMPLEX 
3hns:H   (SER140) to   (ARG214)  CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE  |   ANTIBODY-CARBOHYDRATE COMPLEX, OLIGOFURANOSIDE, TUBERCULOSIS, IMMUNE SYSTEM 
2fec:J   (MET143) to   (PRO220)  STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
2fed:C   (MET143) to   (PRO220)  STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI  |   CLC-EC1; CLCA_ECOLI; CHLORIDE/PROTON EXCHANGE TRANSPORTER, PROTON TRANSPORT,MEMBRANE PROTEIN 
1g7p:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE  |   MHC CLASS I, H-2KB, YEAST, S. CEREVISIAE, ALPHA-GLUCOSIDASE, IMMUNE SYSTEM 
1g7q:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA  |   MHC CLASS I, H-2KB, MUC1, VNTR, MUCIN, IMMUNE SYSTEM 
2fik:A   (GLY202) to   (TRP279)  STRUCTURE OF A MICROBIAL GLYCOSPHINGOLIPID BOUND TO MOUSE CD1D  |   NKT CELLS, CD1D, MHC-FOLD, IMMUNE SYSTEM, BACTERIAL ANTIGEN, TCR 
3uts:E   (GLN141) to   (ARG244)  1E6-A*0201-ALWGPDPAAA COMPLEX, MONOCLINIC  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM 
3huj:C   (ARG201) to   (TRP277)  CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR  |   CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1s7q:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7t:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7u:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7u:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7u:H    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7u:K    (ASN21) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7w:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7w:H    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7w:J   (GLY197) to   (TRP274)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7w:K    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7x:B    (ASN21) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7x:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7x:K    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
3v8c:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
3v95:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
3v95:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
4ku1:A   (ASN361) to   (LEU443)  ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING  |   HUMAN FC FRAGMENT, IMMUNE RESPONSE, IMMUNE SYSTEM 
4ku1:B   (ASN361) to   (LEU443)  ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING  |   HUMAN FC FRAGMENT, IMMUNE RESPONSE, IMMUNE SYSTEM 
1gzp:B    (LEU23) to    (LYS94)  CD1B IN COMPLEX WITH GM2 GANGLIOSIDE  |   LIPID, GANGLIOSIDE, MHC, ANTIGEN PRESENTATION, GLYCOPROTEIN 
3vfn:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*3508LPEP151A, HLA MUTANT ALA151  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vj6:B    (PRO20) to    (TYR94)  STRUCTURE OF THE MHC CLASS IB MOLECULE QA-1B  |   MHC-CLASSIB, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, PEPTIDE PRESENTATION, CD94-NKG2A/C RECEPTORS 
2gj7:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX  |   FC RECEPTOR, LOW RESOLUTION, IMMUNE SYSTEM-VIRUS-VIRAL PROTEIN COMPLEX 
2gj7:B   (ASN361) to   (SER442)  CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX  |   FC RECEPTOR, LOW RESOLUTION, IMMUNE SYSTEM-VIRUS-VIRAL PROTEIN COMPLEX 
4l4j:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4l4t:C   (ALA197) to   (GLN268)  STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP  |   MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
4l4v:C   (THR196) to   (GLN268)  STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH  |   MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
3idg:B   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
3idm:B   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
4zne:E   (ASN361) to   (LEU443)  IGG1 FC-FCGAMMARI ECD COMPLEX  |   ANTIBODY, CONSTANT REGION, RECEPTOR, HIGH AFFINITY, IMMUNE SYSTEM 
4zne:J   (ASN361) to   (LEU443)  IGG1 FC-FCGAMMARI ECD COMPLEX  |   ANTIBODY, CONSTANT REGION, RECEPTOR, HIGH AFFINITY, IMMUNE SYSTEM 
1t7x:A   (LYS200) to   (TRP275)  ZN-ALPHA-2-GLYCOPROTEIN; REFOLDED CHO-ZAG PEG 400  |   MHC CLASS I HOMOLOG, LIPID BINDING PROTEIN 
1t83:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)  |   FC GAMMA RECEPTOR, IGG1, CD16, FCGRIII, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4l8d:A   (GLY197) to   (ARG273)  CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE  |   INFLUENZA, VIRAL ESCAPE, T CELL IMMUNITY, IMMUNE SYSTEM 
4l8s:C   (ILE309) to   (GLN382)  CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1  |   IMMUNOGLOBULIN DOMAIN, MHC-CLASS I, ANTIGEN PRESENTATION, ANTIGEN RECOGNITION, ANTIGEN, CELL MEMBRANE, IMMUNE SYSTEM 
4lcu:A   (MET140) to   (PRO217)  STRUCTURE OF KCSA WITH E118A MUTATION  |   VOLTAGE GATED POTASSIUM CHANNEL, POTASSIUM CHANNEL, TRANSPORT PROTEIN, MEMBRANE PROTEIN, PH-GATED POTASSIUM CHANNEL 
4lcw:C   (THR196) to   (GLN268)  THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH  |   MHC CLASS I-RELATED PROTEIN, MAIT T CELL RECEPTOR, VITAMIN B2 METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
4lcy:F   (HIS197) to   (TRP274)  CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION  |   ANTIGEN PRESENTING, CELL SURFACE, HLA-B46, MEMBRANE PROTEIN 
1hdm:A   (PRO113) to   (PRO190)  HISTOCOMPATIBILITY ANTIGEN HLA-DM  |   HISTOCOMPATIBILITY PROTEIN, IMMUNE SYSTEM 
1hdm:B   (PRO106) to   (PRO184)  HISTOCOMPATIBILITY ANTIGEN HLA-DM  |   HISTOCOMPATIBILITY PROTEIN, IMMUNE SYSTEM 
3ixa:B    (SER20) to    (LYS94)  HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE  |   TEL1P, TAX, A150P MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1hxm:A   (ASN137) to   (SER202)  CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR  |   IG DOMAIN, T CELL RECEPTOR, TCR, GDTCR, IMMUNE SYSTEM 
1hxm:C   (ASN137) to   (SER202)  CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR  |   IG DOMAIN, T CELL RECEPTOR, TCR, GDTCR, IMMUNE SYSTEM 
1hxm:E   (ASN137) to   (SER202)  CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR  |   IG DOMAIN, T CELL RECEPTOR, TCR, GDTCR, IMMUNE SYSTEM 
1hxm:G   (ASN137) to   (SER202)  CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR  |   IG DOMAIN, T CELL RECEPTOR, TCR, GDTCR, IMMUNE SYSTEM 
4lp4:A   (VAL137) to   (ARG228)  CRYSTAL STRUCTURE OF THE HUMAN RAGE VC1 FRAGMENT IN SPACE GROUP P62  |   IMMUNOGLOBULIN FOLD, PATTERN RECOGNITION RECEPTOR, SIGNALING RECEPTOR, MEMBRANE, SIGNALING PROTEIN 
4lp4:B   (VAL137) to   (ARG228)  CRYSTAL STRUCTURE OF THE HUMAN RAGE VC1 FRAGMENT IN SPACE GROUP P62  |   IMMUNOGLOBULIN FOLD, PATTERN RECOGNITION RECEPTOR, SIGNALING RECEPTOR, MEMBRANE, SIGNALING PROTEIN 
1hzh:H   (ASN384) to   (LEU474)  CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN  |   IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM 
1hzh:K   (ASN384) to   (SER473)  CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN  |   IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM 
1i1c:A   (SER361) to   (HIS443)  NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A  |   IGG, FC, IMMUNE SYSTEM 
1i1c:B   (SER361) to   (HIS443)  NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A  |   IGG, FC, IMMUNE SYSTEM 
3vwk:B    (LEU23) to    (LYS94)  TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX  |   CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3vxu:B    (SER20) to    (LYS94)  THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
1i3r:A   (PRO102) to   (GLU179)  CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE  |   MHC CLASSII, IMMUNE SYSTEM 
1i3r:C   (PRO102) to   (GLU179)  CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE  |   MHC CLASSII, IMMUNE SYSTEM 
1i3r:E   (PRO102) to   (GLU179)  CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE  |   MHC CLASSII, IMMUNE SYSTEM 
1i3r:G   (PRO102) to   (GLU179)  CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE  |   MHC CLASSII, IMMUNE SYSTEM 
3w14:C   (SER135) to   (ASP207)  INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14  |   CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
3w14:P   (SER135) to   (ASP207)  INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1,CR,L2, FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14  |   CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
1u3h:G   (PRO102) to   (PRO180)  CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A  |   COMPLEX, IMMUNE SYSTEM 
2htk:C   (MET143) to   (PRO220)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
1u58:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M144  |   MCMV, MHC-I HOMOLOG, M144, BETA-2M, IMMUNE SYSTEM 
1u8h:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8i:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8j:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8l:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8m:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8n:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8o:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8p:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u8q:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u91:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC)  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u93:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC)  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1u95:B   (ALA134) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1i7t:B    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V  |   MHC FOLD, IMMUNE SYSTEM 
1i7t:E    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V  |   MHC FOLD, IMMUNE SYSTEM 
1iea:C   (PRO102) to   (GLU179)  HISTOCOMPATIBILITY ANTIGEN  |   HISTOCOMPATIBILITY ANTIGEN 
1ieb:A   (PRO102) to   (GLU179)  HISTOCOMPATIBILITY ANTIGEN  |   HISTOCOMPATIBILITY ANTIGEN 
1ieb:C   (PRO102) to   (GLU179)  HISTOCOMPATIBILITY ANTIGEN  |   HISTOCOMPATIBILITY ANTIGEN 
1ij9:A   (ILE109) to   (GLU192)  HIGHLY HYDRATED HUMAN VCAM-1 FRAGMENT  |   INTEGRIN SOLVATION, CELL ADHESION 
1inq:B  (LEU1023) to  (TYR1094)  STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13A, COMPLEXED TO H2-DB  |   MINOR HISTOCOMPATIBILITY ANTIGEN, MHC COMPLEX, IMMUNE SYSTEM 
4m4r:E   (SER343) to   (ASN437)  EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5  |   EPH RECEPTOR EPHRIN COMPLEX, TRANSFERASE 
2ian:Q   (HIS112) to   (ALA190)  STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC, MHC CLASS II-RESTRICTED TCR  |   X-RAY CRYSTALLOGRAPHY, MAJOR HISTOCOMPATIBILITY COMPLEX, T CELL RECEPTOR, T CELL STIMULATION, MELANOMA, TUMOR ANTIGEN, IMMUNE SYSTEM 
4m61:A   (GLY133) to   (ASN215)  CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2icw:E   (ASN113) to   (ARG189)  CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR, SUPERANTIGEN, AND PEPTIDE-MHC CLASS II MOLECULE  |   TCR, MHC, SUPERANTIGEN, PROTEIN-PROTEIN COMPLEX, IMMUNE SYSTEM 
3wex:A   (PRO102) to   (ALA180)  CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)  |   IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T CELL RECEPTOR, CELL SURFACE, IMMUNE SYSTEM 
3wex:C   (PRO102) to   (ALA180)  CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)  |   IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T CELL RECEPTOR, CELL SURFACE, IMMUNE SYSTEM 
3wex:E   (PRO102) to   (ALA180)  CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)  |   IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T CELL RECEPTOR, CELL SURFACE, IMMUNE SYSTEM 
1uxs:B    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (HLA/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705, EPSTEIN-BARR VIRUS, 
3wjl:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3wjl:B   (ASN361) to   (SER444)  CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3wkn:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wkn:N   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wn5:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3wn5:B   (ASN361) to   (SER442)  CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3wn5:D   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
1v8h:A    (GLU18) to   (LEU107)  CRYSTAL STRUCTURE OF TT0351 PROTEIN FROM THERMUS THERMOPHILUS HB8  |   LITHOTROPHIC SULFUR OXIDATION, UNKNOWN FUNCTION, STRUCTURAL GENOMICS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI 
2iwg:A   (ASN361) to   (LEU443)  COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC  |   ZINC, RNA-BINDING, ZINC-FINGER, DNA-BINDING, RIBONUCLEOPROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, SYSTEMIC LUPUS ERYTHEMATOSUS, POLYMORPHISM, GLYCOPROTEIN, METAL-BINDING 
2iwg:D   (ASN361) to   (LEU443)  COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC  |   ZINC, RNA-BINDING, ZINC-FINGER, DNA-BINDING, RIBONUCLEOPROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, SYSTEMIC LUPUS ERYTHEMATOSUS, POLYMORPHISM, GLYCOPROTEIN, METAL-BINDING 
1je6:A   (GLY196) to   (VAL272)  STRUCTURE OF THE MHC CLASS I HOMOLOG MICB  |   DELTA-TCR, GLYCOPROTEIN, SIGNA IMMUNOGLOBULIN FOLD, T-CELL, IMMUNE SYSTEM 
3ws3:B    (ASN41) to   (TYR114)  CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE  |   CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, INSULIN, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM 
3ws3:D    (ASN41) to   (TYR114)  CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE  |   CLASS I MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, INSULIN, H-2D, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, IMMUNE SYSTEM 
2j6e:A   (ASN361) to   (SER442)  CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION  |   AUTOIMMUNE COMPLEX HUMAN IGM RHEUMATOID FACTOR IGG1-FC, IMMUNOGLOBULIN C REGION, MEMBRANE, GLYCOPROTEIN, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN 
3j70:B   (THR129) to   (ARG211)  MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B  |   GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3j70:N   (THR129) to   (ARG211)  MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B  |   GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3j70:S   (THR129) to   (ARG211)  MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B  |   GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3j8f:7   (MET163) to   (TYR241)  CRYO-EM RECONSTRUCTION OF POLIOVIRUS-RECEPTOR COMPLEX  |   POLIOVIRUS, RECEPTOR, PVR, CD155, VIRUS-SIGNALING PROTEIN COMPLEX 
1w0v:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1  |   IMMUNE SYSTEM, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2705, MHC I 
4n0f:B    (LEU23) to    (LYS94)  HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN  |   ALPHA/BETA, RECEPTOR, IGG CONSTANT DOMAIN, MEMBRANE, IMMUNE SYSTEM 
4n0f:L    (LEU23) to    (LYS94)  HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN  |   ALPHA/BETA, RECEPTOR, IGG CONSTANT DOMAIN, MEMBRANE, IMMUNE SYSTEM 
3x12:B    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*57:01.I80N  |   IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM 
3x13:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*0801.N80I  |   IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS, LILR, TCR, KIR, PLASMA MEMBRANE, IMMUNE SYSTEM 
4nco:C   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122  |   TYPE-1 MEMBRANE FUSION GLYCOPROTEIN TRIMER, HIV-1 ENVELOPE, GP120, GP41, MEMBRANE FUSION, VIRAL ENTRY, CD4, CCR5/CXCR4, BROADLY NEUTRALIZING ANTIBODIES, VIRAL SURFACE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4nco:G   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122  |   TYPE-1 MEMBRANE FUSION GLYCOPROTEIN TRIMER, HIV-1 ENVELOPE, GP120, GP41, MEMBRANE FUSION, VIRAL ENTRY, CD4, CCR5/CXCR4, BROADLY NEUTRALIZING ANTIBODIES, VIRAL SURFACE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4nco:K   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122  |   TYPE-1 MEMBRANE FUSION GLYCOPROTEIN TRIMER, HIV-1 ENVELOPE, GP120, GP41, MEMBRANE FUSION, VIRAL ENTRY, CD4, CCR5/CXCR4, BROADLY NEUTRALIZING ANTIBODIES, VIRAL SURFACE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5bw7:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA  |   IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA 
1k8i:A   (PRO113) to   (PRO190)  CRYSTAL STRUCTURE OF MOUSE H2-DM  |   MHC, IMMUNE SYSTEM 
1k8i:B   (PRO111) to   (PRO190)  CRYSTAL STRUCTURE OF MOUSE H2-DM  |   MHC, IMMUNE SYSTEM 
1kbg:L    (LEU23) to    (TYR94)  MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2  |   MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, ANTIGEN PRESENTATION, GLYCOPEPTIDE, CELLULAR IMMUNITY, IMMUNOLOGY, CELL SURFACE RECEPTOR, SYNTHETIC PEPTIDE, VACCINE, IMMUNE SYSTEM 
4nhg:M   (GLY144) to   (PRO223)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:D   (GLY144) to   (LYS219)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:E   (GLY144) to   (PRO223)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:I   (GLY144) to   (LYS219)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4npy:H   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF GERMLINE FAB PGT121, A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   IGG-FOLD, ANTI-HIV ANTIBODY PRECURSOR, HIV ENV GP120, IMMUNE SYSTEM 
4nqc:A   (CYS200) to   (GLN268)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
4nqd:A   (GLY194) to   (GLN268)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   IMMUNE COMPLEX, MR1, T-CELL RECEPTOR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
4nqd:C   (ALA197) to   (GLN268)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   IMMUNE COMPLEX, MR1, T-CELL RECEPTOR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
2mcp:H   (PRO143) to   (CYS222)  REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
1kpr:B    (LEU23) to    (LYS94)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM 
1kpr:D    (SER20) to    (LYS94)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM 
1kpu:B    (PRO20) to    (TYR94)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/VSV8  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE-MHC, IMMUNE SYSTEM 
2mha:B    (PRO20) to    (ARG97)  CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION  |   HISTOCOMPATIBILITY ANTIGEN 
1kt2:A   (PRO102) to   (PHE180)  CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE  |   PROTEIN-PEPTIDE COMPLEX, T CELL RECEPTOR, ANTIGEN PRESENTATION, CYTOCHROME, IMMUNE SYSTEM 
1ktl:B    (SER20) to    (LYS94)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM 
1ktl:D    (SER20) to    (LYS94)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   HLA-E, MHC, NON-CLASSICAL MHC, HLA, BETA 2 MICROGLOBULIN, IMMUNE SYSTEM 
1l6x:A   (ASN361) to   (LEU443)  FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C  |   IGG1 FC, PROTEIN A, FC COMPLEX, B-DOMAIN, IMMUNE SYSTEM 
2nx5:G    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
2nx5:L    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
1leg:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE  |   MHC CLASS I MOLECULE WITH BOUND PEPTIDE, IMMUNE SYSTEM 
4of0:A   (ILE148) to   (TYR268)  CRYSTAL STRUCTURE OF SYG-1 D1-D2, REFOLDED  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4of5:A   (CYS144) to   (PRO232)  REFINEMENT OF RAGE-DNA COMPLEX IN 3S59 WITHOUT DNA  |   MEMBRANE, SIGNALING PROTEINIG DOMAIN, RECEPTOR, S100 PROTEINS AB OLIGOMER AGE DNA, SIGNALING PROTEIN 
4of5:B   (CYS144) to   (PRO232)  REFINEMENT OF RAGE-DNA COMPLEX IN 3S59 WITHOUT DNA  |   MEMBRANE, SIGNALING PROTEINIG DOMAIN, RECEPTOR, S100 PROTEINS AB OLIGOMER AGE DNA, SIGNALING PROTEIN 
4of8:A   (ARG149) to   (TYR235)  CRYSTAL STRUCTURE OF RST D1-D2  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, MYOBLAST FUSION, EYE DEVELOPMENT, PROTEIN BINDING, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4of8:C   (ARG149) to   (LYS234)  CRYSTAL STRUCTURE OF RST D1-D2  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, MYOBLAST FUSION, EYE DEVELOPMENT, PROTEIN BINDING, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4ofk:B   (SER346) to   (PRO430)  CRYSTAL STRUCTURE OF SYG-2 D4  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4ofp:A   (GLY345) to   (ALA429)  CRYSTAL STRUCTURE OF SYG-2 D3-D4  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4ofp:D   (GLY345) to   (ALA429)  CRYSTAL STRUCTURE OF SYG-2 D3-D4  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4ofv:A   (CYS144) to   (VAL233)  REFINEMENT OF RAGE-DNA COMPLEX IN 3S58 WITHOUT DNA  |   IG DOMAIN, RECEPTOR, S100 PROTEINS ADVANCED GLYCATION END PRODUCTS AB OLIGOMERS DNA, MEMBRANE, PROTEIN BINDING 
4ofv:B   (CYS144) to   (PRO232)  REFINEMENT OF RAGE-DNA COMPLEX IN 3S58 WITHOUT DNA  |   IG DOMAIN, RECEPTOR, S100 PROTEINS ADVANCED GLYCATION END PRODUCTS AB OLIGOMERS DNA, MEMBRANE, PROTEIN BINDING 
4ofy:E   (GLY345) to   (ALA429)  CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
4oi9:A   (ARG214) to   (LEU298)  CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT, SPACE GROUP P21  |   CELL ADHESION, CELL SURFACE, NEURONS, IMMUNOGLOBULIN SUPERFAMILY, INTERCELLULAR ADHESION MOLECULES, ICAM-5, TELENCEPHALIN 
1lo5:B   (ASN113) to   (ARG189)  CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II  |   PROTEIN-PROTEIN COMPLEX, IMMUNE SYSTEM/TOXIN COMPLEX 
1lp9:B    (SER20) to    (LYS94)  XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1  |   IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM 
4ong:H   (MET141) to   (LYS215)  FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40  |   ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM 
1xr9:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B62, HLA-B*1501, COMPLEX (ANTIGEN-PEPTIDE), IMMUNE SYSTEM-LIGASE COMPLEX 
2zol:A   (GLY197) to   (TRP274)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510  |   IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, POLYMORPHISM, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, COILED COIL, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE 
2zol:C   (GLY197) to   (TRP274)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510  |   IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, POLYMORPHISM, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, COILED COIL, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE 
2zok:B    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510  |   IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE 
2zok:D    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510  |   IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE 
2zok:F    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510  |   IMMUNE SYSTEM, IG FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, FUSION PROTEIN, HOST-VIRUS INTERACTION, VIRION, VIRULENCE 
4acp:B   (ASN361) to   (LEU443)  DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT  |   IMMUNE SYSTEM, IGG, ANTIBODY, KIFUNENSINE 
3kla:A   (HIS197) to   (TRP274)  CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR  |   MHC, TUMOUR, IMMUNOLOGY, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4ozg:B   (ASN113) to   (ALA190)  D2 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozh:A   (PRO102) to   (PRO180)  S16 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozh:F   (GLN152) to   (ALA256)  S16 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozi:A   (GLN101) to   (PRO180)  S2 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozi:C   (GLN101) to   (PRO180)  S2 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
5d2l:N    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2  |   TCR, HCMV, HLA-A2, COMPLEX, IMMUNE SYSTEM 
4p2r:A   (PRO102) to   (GLU179)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2r:F   (PRO102) to   (PHE180)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2r:P   (PRO102) to   (PHE180)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2o:A   (PRO102) to   (PHE180)  CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH 2A/I-EK  |   T CELL RECEPTOR, IMMUNE SYSTEM, PEPTIDE-MHC, COMPLEX 
4p4k:A   (PRO102) to   (GLU179)  STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY  |   BE BOUND COMPLEX, CHRONIC BERYLLIUM DISEASE, TCR-MHC PEPTIDE-BE2+, IMMUNE SYSTEM 
4p4k:E   (PRO102) to   (ALA180)  STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY  |   BE BOUND COMPLEX, CHRONIC BERYLLIUM DISEASE, TCR-MHC PEPTIDE-BE2+, IMMUNE SYSTEM 
4p4r:A   (GLN101) to   (GLU179)  STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY  |   HLA-DP2, IMMUNE SYSTEM, ALLERGY, BERYLLIOSIS 
4p4r:C   (GLN101) to   (GLU179)  STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY  |   HLA-DP2, IMMUNE SYSTEM, ALLERGY, BERYLLIOSIS 
4p57:C   (PRO102) to   (ALA180)  MHC TCR PEPTIDE COMPLEX  |   MHC TCR PEPTIDE BE2+ COMPLEX, BERYLLIOSIS, IMMUNE SYSTEM 
4p5m:A   (PRO102) to   (ALA180)  STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY  |   CBD, AUTOIMMUNITY, BERYLLIUM, IMMUNE SYSTEM 
4p5m:C   (PRO102) to   (ALA180)  STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY  |   CBD, AUTOIMMUNITY, BERYLLIUM, IMMUNE SYSTEM 
4p5m:G   (PRO102) to   (ALA180)  STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY  |   CBD, AUTOIMMUNITY, BERYLLIUM, IMMUNE SYSTEM 
4p5t:G   (GLN101) to   (TRP178)  14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE  |   MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3kpm:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpn:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpo:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpq:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM-PEPTIDE COMPLEX 
5d4q:B   (ASN361) to   (SER442)  CRYSTAL STRUCTURE OF GASDALIE IGG1 FC  |   ADCC, IGG FC, IMMUNE SYSTEM 
5d5m:C   (VAL195) to   (GLN268)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, IMMUNE SYSTEM 
5d6d:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA  |   ADCC, IMMUNE SYSTEM, IGG 
5d7i:A   (GLY194) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, RECEPTOR, IMMUNE SYSTEM 
5d7j:E   (VAL195) to   (GLN268)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR  |   RECEPTOR, ANTIGEN, IMMUNE SYSTEM 
5d7l:A   (VAL195) to   (GLN268)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR  |   RECEPTOR, ANTIGEN, IMMUNE SYSTEM 
1muj:A   (PRO102) to   (SER179)  CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE  |   I-AB, CLIP, COMPLEX, ANTIGEN, IMMUNE SYSTEM 
3kym:F   (SER140) to   (ARG219)  CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB  |   IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM 
1n2r:B    (LEU23) to    (LYS94)  A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION.  |   MHC I, SIGNAL, IMMUNE SYSTEM 
4pge:B    (PRO20) to    (TYR94)  MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAW  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM- PEPTIDE COMPLEX 
1n3n:B    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n3n:D    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n3n:F    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n3n:H    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1n59:D    (LEU23) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
3l3d:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3g:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3i:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
4pj7:F   (GLN137) to   (GLY239)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
5di8:A   (ASN361) to   (LEU443)  FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5di8:B   (ASN361) to   (LEU443)  FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
4pj8:A   (VAL195) to   (GLN268)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pjb:A   (VAL195) to   (VAL269)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pjb:C   (THR196) to   (GLN268)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pjc:C   (THR196) to   (GLN268)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pjd:C   (THR196) to   (VAL269)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pje:C   (ALA197) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pjf:C   (ALA197) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pjg:C   (CYS200) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pjh:C   (ALA197) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pji:C   (ALA197) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
5dj0:A   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj0:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj2:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
4pjx:A   (GLY194) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pjx:C   (ALA197) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
5dj6:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj8:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dja:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 9.1 Y407M + T366I  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djd:A   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 5.1 T366V + Y407F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djd:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 5.1 T366V + Y407F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:A   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:D   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:E   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djy:B   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dk2:B   (ASN361) to   (LEU443)  FC HETERODIMER E356K/D399K + K392D/K409D  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
3agv:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX  |   IGG, RNA APTAMER, IMMUNE SYSTEM-RNA COMPLEX 
5dmk:F   (HIS115) to   (TRP191)  CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14  |   CHROMOGRANIN A, TYPE I DIABETES, T CELL, FUSION PROTEIN, IMMUNE SYSTEM 
5dmk:H   (ASN116) to   (TRP191)  CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14  |   CHROMOGRANIN A, TYPE I DIABETES, T CELL, FUSION PROTEIN, IMMUNE SYSTEM 
3lcy:A    (GLU23) to   (THR100)  TITIN IG TANDEM DOMAINS A164-A165  |   TITIN, A-BAND, IG TANDEM DOMAINS, ATP-BINDING, CALMODULIN-BINDING, CARDIOMYOPATHY, DISEASE MUTATION, DISULFIDE BOND, IMMUNOGLOBULIN DOMAIN, ISOPEPTIDE BOND, KELCH REPEAT, KINASE, LIMB-GIRDLE MUSCULAR DYSTROPHY, MAGNESIUM, METAL-BINDING, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TPR REPEAT, TRANSFERASE, WD REPEAT 
3alp:B   (VAL169) to   (GLY253)  CELL ADHESION PROTEIN  |   IMMUNOGLOBULIN-LIKE DOMAIN, V-SET, C2-SET, CELL ADHESION 
5dsc:C   (SER134) to   (ALA209)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM 
5dsc:H   (SER134) to   (PRO210)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM 
4apq:A   (GLY202) to   (TRP279)  CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE  |   IMMUNITY, APC CELL SURFACE, IMMUNE SYSTEM 
1zhb:B    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
1zhb:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
1zhb:H    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
1zhb:K    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE  |   MHC, TCR-CROSSREACTIVITY, SELF-LIGAND, AUTOIMMUNITY, IMMUNE SYSTEM 
5dvl:A   (ASN361) to   (SER440)  FC DESIGN 20.8.37 A CHAIN HOMODIMER Y349S/T366M/K370Y/K409V  |   HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM 
4at6:G   (MET140) to   (PRO217)  FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7  |   IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE 
5dyo:A   (SER134) to   (PRO212)  FAB43.1 COMPLEX WITH FLOURESCEIN  |   ANTIBODY FAB FLOURESCEIN, IMMUNE SYSTEM 
1zt7:B    (LEU23) to    (ARG97)  CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE  |   PEPTIDE BINDING GROOVE, IMMUNE SYSTEM 
1zt7:D    (LEU23) to    (ARG97)  CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE  |   PEPTIDE BINDING GROOVE, IMMUNE SYSTEM 
4q6y:B   (ASN361) to   (SER442)  CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)  |   IMMUNE SYSTEM 
4q74:A   (ASN361) to   (LEU443)  F241A FC  |   IMMUNE SYSTEM 
3ave:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1  |   IMMUNOGLOBULIN, IGG1, IMMUNE SYSTEM, IMMUNOGLOBULIN-LIKE BETA- SANDWICH 
5e8n:E    (ASN21) to    (ARG97)  THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)  |   CANCER, NEO-EPITOPE, TAP-DEFICIENCY, TEIPP, MHC-I, SULFUR-PI INTERACTIONS, NON-CLASSICAL PEPTIDE BINDING, IMMUNE SYSTEM 
5e8p:B    (ASN21) to    (TYR94)  THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P5NLE IN COMPLEX WITH H-2D(B)  |   CANCER, NEO-EPITOPE, TAP-DEFICIENCY, TEIPP, MHC-I, SULFUR-PI INTERACTIONS, NON-CLASSICAL PEPTIDE BINDING, IMMUNE SYSTEM 
5e8p:E    (ASN21) to    (TYR94)  THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P5NLE IN COMPLEX WITH H-2D(B)  |   CANCER, NEO-EPITOPE, TAP-DEFICIENCY, TEIPP, MHC-I, SULFUR-PI INTERACTIONS, NON-CLASSICAL PEPTIDE BINDING, IMMUNE SYSTEM 
3m17:H    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-INHIBITOR COMPLEX 
3m1b:F    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
3m1b:H    (ASN21) to    (LYS94)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
3ay4:B   (ASN361) to   (SER440)  CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA  |   IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA 
4b53:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE ISOLATED IGG4 CH3 DOMAIN  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB ARM EXCHANGE, IGG1 
5efi:A   (HIS203) to   (TRP279)  CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH THE P99P LIPOPEPTIDE  |   CD1D, LIPOPEPTIDE, ALPHA-HELICAL PEPTIDE, IMMUNE SYSTEM 
3b3i:B    (LEU23) to    (LYS94)  CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES  |   HLA-B2709, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, G-PROTEIN COUPLED RECEPTOR, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, PROTEIN BINDING, IMMUNE SYSTEM 
3b43:A   (PHE113) to   (LEU198)  I-BAND FRAGMENT I65-I70 FROM TITIN  |   I-SET IG FOLD, EXTENDED POLY-IG FILAMENT, TITIN, ELASTIC FILAMENT, STRUCTURAL PROTEIN 
3mbe:E   (PRO102) to   (SER180)  TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)  |   T CELL RECEPTOR, HISTOCOMPATABILITY ANTIGEN, MHC CLASS II, I-AG7, IMMUNE SYSTEM 
5eo0:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B0702-RFL9  |   TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
5eo1:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B0702-RL9  |   TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
3bev:B    (LYS19) to    (PHE98)  11MER STRUCTURE OF AN MHC CLASS I MOLECULE FROM B21 CHICKENS ILLUSTRATE PROMISCUOUS PEPTIDE BINDING  |   MHC CLASS I, CHICKEN, B21, BF21, 11MER, PEPTIDE, BULGE, WATER CUSHION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, POLYMORPHISM, SECRETED, HEME, IRON, METAL-BINDING, OXYGEN TRANSPORT, TRANSPORT, IMMUNE SYSTEM 
3bew:E    (LYS19) to    (PHE98)  10MER CRYSTAL STRUCTURE OF CHICKEN MHC CLASS I HAPLOTYPE B21  |   MHC CLASS I, CHICKEN, 10MER, BULGE, PEPTIDE, WATER CUSHION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, POLYMORPHISM, SECRETED, GTP-BINDING, MICROTUBULE, NUCLEOTIDE-BINDING, IMMUNE SYSTEM 
3mlt:H   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
4qrp:G    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR  |   HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM 
4qrs:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELK_IYM, ELKRKMIYM  |   HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM 
4qrt:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELN_YYM, ELNRKMIYM  |   HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM 
4qru:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELR_MYM, ELRRKMMYM  |   HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM 
5euo:D    (SER20) to    (LYS94)  PF6-M1-HLA-A2  |   TCR, FLU, MHC, IMMUNE SYSTEM 
4bk4:A   (SER343) to   (THR435)  CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN  |   SIGNALING PROTEIN, CELL ADHESION, CELL REPULSION, RECEPTOR CLUSTERING, RECEPTOR CIS INTERACTION, EPH-EPHRIN CRYSTAL STRUCTURES, EPH ECTODOMAIN, ERYTHROPOETIN-PRODUCING HEPATOCELLULAR RECEPTOR, LBD, EGF, FN 
4bkf:A   (SER343) to   (ASN437)  CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3  |   TRANSFERASE, CELL ADHESION, CELL REPULSION, RECEPTOR CLUSTERING, RECEPTOR CIS INTERACTION, ERYTHROPOETIN-PRODUCING HEPATOCELLULAR RECEPTOR, LBD, SUSHI, EGF, FN 
4bkf:B   (SER343) to   (ASN437)  CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3  |   TRANSFERASE, CELL ADHESION, CELL REPULSION, RECEPTOR CLUSTERING, RECEPTOR CIS INTERACTION, ERYTHROPOETIN-PRODUCING HEPATOCELLULAR RECEPTOR, LBD, SUSHI, EGF, FN 
3bp7:B    (LEU23) to    (LYS94)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B*2709, HLA-B2709, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A SIGNAL SEQUENCE, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
4qxu:H   (MET140) to   (PRO217)  NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY  |   STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, IGG FOLD, IMMUNE SYSTEM 
3myj:E    (SER20) to    (LYS94)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.  |   WT-1 PEPTIDE, R1Y MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3c5z:C   (PRO103) to   (PRO181)  CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506  |   TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX 
3c5z:G   (PRO103) to   (PRO181)  CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506  |   TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX 
4r7d:D   (GLY128) to   (ASN210)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4byh:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF SIALYLATED IGG FC  |   IMMUNE SYSTEM, ANTIBODY, SIALYATION, IMMUNOGLOBULIN 
3cch:B    (ASN21) to    (TYR94)  H-2DB COMPLEX WITH MURINE GP100  |   MURINE MHC, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, MELANIN BIOSYNTHESIS, IMMUNE SYSTEM 
3nfn:B    (SER20) to    (LYS94)  RECOGNITION OF PEPTIDE-MHC BY A V-DELTA/V-BETA TCR  |   IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM 
4rfe:E   (SER134) to   (GLU212)  CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB  |   HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM 
4c54:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN, IGG1 
4c54:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN, IGG1 
4c4k:O    (LYS25) to   (ASP100)  CRYSTAL STRUCTURE OF THE TITIN M10-OBSCURIN IG DOMAIN 1 COMPLEX  |   TRANSFERASE, SARCOMERE, IMMUNOGLOBULIN DOMAIN, LIMB-GIRDLE MUSCULAR DYSTROPHY 
4c55:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, ANTIBODY, IMMUNOGLOBULIN, IGG1 
4c83:A   (SER134) to   (PRO212)  CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS  |   IMMUNE SYSTEM, LIPOOLIGOSACCHARIDES, ANTIBODIES, ANTIGEN-ANTIBODY COMPLEX 
4cdh:A   (ASN142) to   (LEU224)  CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT  |   IMMUNE SYSTEM, C-LECTIN CRD, SIGN-R1, INMUNE SYSTEM, CAPSULAR POLYSACCHARIDE 
3cpl:D    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS  |   H-2DB, CRYSTAL STRUCTURE, INFLUENZA, NP366, IMMUNOLOGY, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, POLYMORPHISM, SECRETED, IMMUNE SYSTEM 
3cvh:B    (LEU23) to    (ARG97)  HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE  |   MHC, TCR, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, ALLERGEN, PHOSPHOPROTEIN, SECRETED, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3cxd:H   (SER137) to   (PRO215)  CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE  |   FAB, OSTEOPONTIN, OPN, ANTIBODY-ANTIGEN COMPLEX, IMMUNE SYSTEM 
5fyj:D   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01  |   VIRAL PROTEIN, HIV, ENVELOPE, GLYCAN, TRIMER 
3d18:B    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM-COMPLEX, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, IMMUNE SYSTEM 
3d6g:A   (ASN361) to   (LEU443)  FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.  |   FC FRAGMENT, IGG1, GLYCOSILATED PROTEIN, PROTEIN A MIMETIC PEPTIDE DENDRIMER LIGAND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
3dbx:A   (VAL203) to   (HIS285)  STRUCTURE OF CHICKEN CD1-2 WITH BOUND FATTY ACID  |   CD1, EVOLUTION, ANTIGEN-PRESENTATION, MHC-FOLD, HYDROPHOBIC BINDING GROOVE, IMMUNOGLOBULIN DOMAIN, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3of6:A   (GLN142) to   (TRP243)  HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE  |   IG FOLD, IMMUNE SYSTEM 
4d2n:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1 
4d2n:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1 
4d2n:C   (ASN361) to   (SER442)  CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1 
3do3:B   (ASN361) to   (LEU443)  HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE  |   IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
4d8p:D   (ASN113) to   (ARG189)  STRUCTURAL AND FUNCTIONAL STUDIES OF THE TRANS-ENCODED HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) MOLECULE  |   CLASS II MHC, IMMUNE SYSTEM 
3dx8:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:B    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:G    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:L    (SER20) to    (LYS94)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
5hgd:B    (SER20) to    (LYS94)  HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgd:E    (SER20) to    (LYS94)  HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgh:B    (SER20) to    (LYS94)  HLA*A2402 COMPLEXED WITH HIV NEF138 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hsf:A   (ASN335) to   (LEU417)  1.52 ANGSTROM CRYSTAL STRUCTURE OF FC FRAGMENT OF HUMAN IGG1.  |   FC FRAGMENT, IGG1, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, IMMUNE SYSTEM 
5hsf:B   (ASN335) to   (LEU417)  1.52 ANGSTROM CRYSTAL STRUCTURE OF FC FRAGMENT OF HUMAN IGG1.  |   FC FRAGMENT, IGG1, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, IMMUNE SYSTEM 
5hyj:A   (HIS197) to   (TRP274)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5hyj:F   (HIS197) to   (TRP274)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
4dz8:A   (ASN361) to   (LEU443)  HUMAN IGG1 FC FRAGMENT HETERODIMER  |   FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM 
4dz8:B   (ASN361) to   (LEU443)  HUMAN IGG1 FC FRAGMENT HETERODIMER  |   FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM 
4edw:H   (THR135) to   (ARG213)  NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)  |   CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM 
5ijv:H   (SER170) to   (PRO248)  CRYSTAL STRUCTURE OF BOVINE FAB E03  |   ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM 
5ijv:B   (SER170) to   (PRO248)  CRYSTAL STRUCTURE OF BOVINE FAB E03  |   ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM 
5ijv:F   (SER170) to   (PRO248)  CRYSTAL STRUCTURE OF BOVINE FAB E03  |   ANTIBODY FAB ULTRALONG CDR H3, IMMUNE SYSTEM 
3pwv:B    (PRO20) to    (LYS93)  AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801 (BOLA-A11)  |   MHC BOLA-A11 CONFORMATION CATTLE, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
3pwv:E    (PRO20) to    (LYS93)  AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801 (BOLA-A11)  |   MHC BOLA-A11 CONFORMATION CATTLE, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
4elm:C   (GLY202) to   (TRP279)  CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX  |   ANTIGEN PRESENTATION, GLYCOLIPID, NKT CELLS, IMMUNE SYSTEM 
4ene:C   (MET143) to   (PRO220)  STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX  |   MEMBRANE PROTEIN, COUPLED ION TRANSPORTER, CELL MEMBRANE, TRANSPORT PROTEIN 
4eup:B    (SER20) to    (LYS94)  THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE  |   NONAPEPTIDE, MHC CLASS I, CROSS-REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM 
5j1a:A   (GLY200) to   (TYR276)  ANTIGEN PRESENTING MOLECULE  |   CD1 MOLECULES IMMUNITY, IMMUNE SYSTEM-INHIBITOR COMPLEX 
5j1a:B    (LEU23) to    (ASP98)  ANTIGEN PRESENTING MOLECULE  |   CD1 MOLECULES IMMUNITY, IMMUNE SYSTEM-INHIBITOR COMPLEX 
3qiw:A   (PRO102) to   (PHE180)  CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK  |   IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, MHC MOLECULE, IMMUNE SYSTEM 
4f7c:A   (GLY200) to   (HIS279)  CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE  |   PROTEIN-GLYCOLIPID COMPLEX, MHC-FOLD, IG-FOLD, ANTIGEN PRESENTATION, TCR, MEMBRANE, IMMUNE SYSTEM 
4f7c:B    (LEU23) to    (LYS93)  CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE  |   PROTEIN-GLYCOLIPID COMPLEX, MHC-FOLD, IG-FOLD, ANTIGEN PRESENTATION, TCR, MEMBRANE, IMMUNE SYSTEM 
4f7c:C   (GLY200) to   (HIS278)  CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE  |   PROTEIN-GLYCOLIPID COMPLEX, MHC-FOLD, IG-FOLD, ANTIGEN PRESENTATION, TCR, MEMBRANE, IMMUNE SYSTEM 
4f80:A   (ILE133) to   (ALA209)  CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN  |   B7 SUPERFAMILY, BUTYROPHILIN, CD277, IMMUNE SYSTEM 
4f8t:A   (ILE133) to   (ALA209)  CRYSTAL STRUCTURE OF THE HUMAN BTN3A3 ECTODOMAIN  |   B7 SUPERFAMILY, BUTYROPHILIN, CD277, IMMUNE SYSTEM 
4f9l:B   (ILE133) to   (ILE208)  CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY  |   B7 SUPERFAMILY, BUTYROPHILIN, CD277, IMMUNE SYSTEM 
3qq3:E    (LEU25) to    (LYS95)  CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES  |   SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF INFLUENZA VIRUS, IMMUNE SYSTEM 
3quk:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4A)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, T CELL RECEPTOR, CELL SURFACE 
4w4o:A   (ASN361) to   (LEU443)  HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI  |   IMMUNE COMPLEX IGG1 PROTEIN-PROTEIN COMPLEX ASYMMETRY, IMMUNE SYSTEM 
4w4o:B   (ASN361) to   (LEU443)  HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI  |   IMMUNE COMPLEX IGG1 PROTEIN-PROTEIN COMPLEX ASYMMETRY, IMMUNE SYSTEM 
4fqx:C   (PRO116) to   (PRO193)  CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1  |   IMMUNE COMPLEX, PEPTIDE LOADING, PEPTIDE EDITING, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
4fqx:D   (PRO112) to   (PRO191)  CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1  |   IMMUNE COMPLEX, PEPTIDE LOADING, PEPTIDE EDITING, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
4g8g:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10  |   TCR, T CELL, HLA B*2705, KK10, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
4gbx:D   (PRO112) to   (PRO191)  CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5  |   IMMUNE COMPLEX, PEPTIDE LOADING, PEPTIDE EDITING, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
5ksb:D   (LEU114) to   (ARG189)  T15-DQ8.5-GLIA-GAMMA1 COMPLEX  |   CELIAC DISEASE T CELL RECEPTOR PEPTIDE MHC COMPLEX, IMMUNE SYSTEM 
5swz:J   (LYS152) to   (ALA255)  CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX  |   H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM 
5sx4:J   (THR141) to   (GLU218)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
1nc2:D   (SER140) to   (PRO218)  CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA  |   ANTIBODY-DOTA COMPLEX, RARE EARTH, DOTA, METAL CHELATE, YTTRIUM, GAMMA TURN, N-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
3roo:B    (PRO20) to    (TYR94)  MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE  |   T-CELL RECEPTOR, MHC, GP34, NY-GP34, EPITOPE, POST-TRANSLATIONAL MODIFICATION, LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM, T CELL RECOGNITION, AUTOIMMUNITY, T CELL RECEPTOR, CELL SURFACE 
3roo:D    (LEU23) to    (TYR94)  MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE  |   T-CELL RECEPTOR, MHC, GP34, NY-GP34, EPITOPE, POST-TRANSLATIONAL MODIFICATION, LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM, T CELL RECOGNITION, AUTOIMMUNITY, T CELL RECEPTOR, CELL SURFACE 
4wi6:A   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi6:B   (ASN361) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
1ay1:H   (VAL132) to   (PRO208)  ANTI TAQ FAB TP7  |   IMMUNOGLOBULIN, ANTIBODY, FAB, ENZYME INHIBITOR, PCR, HOT START 
2bc4:A   (PRO116) to   (PRO193)  CRYSTAL STRUCTURE OF HLA-DM  |   MHC CLASS II, IMMUNE SYSTEM 
2bc4:C   (PRO116) to   (PRO193)  CRYSTAL STRUCTURE OF HLA-DM  |   MHC CLASS II, IMMUNE SYSTEM 
4hh8:A   (GLU133) to   (SER208)  CRYSTAL STRUCTURE OF BOVINE BUTYROPHILIN  |   IMMUNOGLOBULIN FOLD, MILK FAT GLOBULE, PROTEIN BINDING 
4x6f:A   (GLY200) to   (TYR276)  CD1A BINARY COMPLEX WITH SPHINGOMYELIN  |   CD1A, IMMUNE COMPLEX, LIPID ANTIGEN, TCR 
4hs3:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF H-2KB WITH A DISULFIDE STABILIZED F POCKET IN COMPLEX WITH THE LCMV DERIVED PEPTIDE GP34  |   MHC CLASS I, ANTIGEN PRESENTATION, ANTIGEN PROCESSING, PEPTIDE BINDING, IGG, MHC, IMMUNE SYSTEM 
1of2:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN) 
3fjt:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE  |   FC, IGG1, FCRN BINDING, CH3-CH3 ASSOCIATION, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
3spv:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF A PEPTIDE-HLA COMPLEX  |   IMMUNOLOGY, RECEPTOR, HLA, HLA-B*0801, EBV, MHC, TCR, T CELL, IMMUNE SYSTEM 
1p1z:B    (ASN21) to    (TYR94)  X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2KB  |   NK, KB, MHC, ANTIGENIC PEPTIDE, LY49, OVA, IMMUNE SYSTEM 
1p4l:B    (ASN21) to    (TRP95)  CRYSTAL STRUCTURE OF NK RECEPTOR LY49C MUTANT WITH ITS MHC CLASS I LIGAND H-2KB  |   NATURAL KILLER RECEPTOR, MHC CLASS I, CRYSTAL STRUCTURE, C- TYPE LECTIN-LIKE DOMAIN, IMMUNE SYSTEM 
1pg7:Z   (SER134) to   (PRO212)  MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB  |   IMMUNE SYSTEM 
3gsn:H   (HIS197) to   (TRP274)  CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE  |   HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1fg2:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
1fg2:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
1fg2:H    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
1fg2:K    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB  |   IG FOLD, IMMUNE SYSTEM 
1frt:B    (LEU23) to    (THR94)  CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC  |   COMPLEX (RECEPTOR-IMMUNOGLOBULIN), COMPLEX (RECEPTOR-IMMUNOGLOBULIN) COMPLEX 
1rk0:B    (PRO20) to    (TYR94)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE  |   MHC, CLASS I, PEPTIDE, VIRUS, TCR, HERPES, IMMUNE SYSTEM 
1fzo:B    (PRO20) to    (TYR94)  MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN  |   MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM 
1s7s:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7v:A   (GLY197) to   (ARG273)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7v:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7v:D   (GLY197) to   (ARG273)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s7v:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
2fwo:B    (LEU23) to    (TYR94)  MHC CLASS I H-2KD HEAVY CHAIN IN COMPLEX WITH BETA- 2MICROGLOBULIN AND PEPTIDE DERIVED FROM INFLUENZA NUCLEOPROTEIN  |   MHC, ANTIGENS/PEPTIDES/EPITOPES, ANTIGEN PROCESSING/PRESENTATION, IMMUNE SYSTEM/VIRAL PROTEIN COMPLEX 
3v7m:A   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
3i50:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB  |   ANTIBODY, FAB, VIRUS, ENVELOPE, IMMUNOGLOBULIN, FUSION LOOP, DISULFIDE BOND, ENVELOPE PROTEIN, MEMBRANE, TRANSMEMBRANE, VIRION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4l29:P    (LEU23) to    (LYS94)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l3c:A   (HIS197) to   (TRP274)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
2w59:A   (SER471) to   (LYS564)  STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT  |   IMMUNOGLOBULIN, AVIAN, IGY FC, IMMUNE SYSTEM 
2w59:B   (SER471) to   (LYS564)  STRUCTURE OF AN AVIAN IGY-FC 3-4 FRAGMENT  |   IMMUNOGLOBULIN, AVIAN, IGY FC, IMMUNE SYSTEM 
1tet:H   (MET135) to   (PRO212)  CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS  |   IMMUNOGLOBULIN 
2wah:B   (ASN361) to   (PRO445)  CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)  |   IMMUNOGLOBULIN C REGION, ANTIBODY ENGINEERING, IMMUNOGLOBULIN DOMAIN, SECRETED, ANTIBODY, KIFUNENSINE, GLYCOPROTEIN, OLIGOMANNOSE, IMMUNE SYSTEM, GLYCOSYLATION 
4zyp:D   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4lp5:B   (VAL137) to   (GLU231)  CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN RAGE EXTRACELLULAR DOMAIN (VC1C2 FRAGMENT)  |   IMMUNOGLOBULIN FOLD, PATTERN RECOGNITION RECEPTOR, SIGNALING RECEPTOR, MEMBRANE, SIGNALING PROTEIN 
1u92:B   (ALA135) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC)  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
2igf:H   (SER136) to   (PRO227)  CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS  |   IMMUNOGLOBULIN 
1uxw:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM-PEPTIDE COMPLEX, COMPLEX (ANTIGEN/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2709 
3wjj:B   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
1vad:B    (PRO20) to    (TYR94)  MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE  |   HISTOCOMPATIBILITY ANTIGEN, CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC I, PEPTIDE, COMPLEX (MHC I/PEPTIDE) COMPLEX 
1vca:A   (LYS107) to   (GLU192)  CRYSTAL STRUCTURE OF AN INTEGRIN-BINDING FRAGMENT OF VASCULAR CELL ADHESION MOLECULE-1 AT 1.8 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN SUPERFAMILY, INTEGRIN-BINDING, CELL ADHESION PROTEIN 
2xfx:B    (PRO21) to    (LYS94)  CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA  |   IMMUNE SYSTEM, MAJOR HISTOCOMPATIBILITY, EAST COAST FEVER, THEILERIOSIS 
4n0u:B    (LEU23) to    (LYS94)  TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR, SERUM ALBUMIN AND FC  |   ALPHA/BETA, DNA BINDING PROTEIN 
2jix:D   (THR138) to   (PRO216)  CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR  |   IMMUNE SYSTEM, RECEPTOR, TRANSMEMBRANE, RECEPTOR SOLUBLE DOMAIN, ANTIBODY, RECEPTOR-IMMUNE SYSTEM COMPLEX 
5cgy:C   (GLY148) to   (PRO227)  FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21  |   ANTIBODY, FAB, IMMUNE SYSTEM 
1lek:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8  |   MHC CLASS I ALLOGENEIC COMPLEX WITH PEPTIDE, IMMUNE SYSTEM 
2zck:H   (SER134) to   (ARG213)  CRYSTAL STRUCTURE OF A TERNARY COMPLEX BETWEEN PSA, A SUBSTRAT-ACYL INTERMEDIATE AND AN ACTIVATING ANTIBODY  |   HUMAN PSA, ANTIBODIES, KALLIKREIN RELATED PEPTIDASES, PROSTATE CANCER, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
1mfc:H   (MET390) to   (PRO467)  HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA  |   IMMUNOGLOBULIN 
1mfd:H   (MET390) to   (PRO467)  THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE  |   IMMUNOGLOBULIN 
4p2q:A   (PRO102) to   (GLU179)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2q:F   (PRO102) to   (PHE180)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2q:P   (PRO102) to   (PHE180)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
3kpl:B    (LEU23) to    (LYS94)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, IMMUNE SYSTEM 
1ydp:B    (LEU23) to    (LYS94)  1.9A CRYSTAL STRUCTURE OF HLA-G  |   IMMUNE SYSTEM 
3aaz:A   (GLY146) to   (PRO225)  CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY  |   ANTIBODY ENGINEERING, HUMANIZATION, HWO-2 FAB, IMMUNE SYSTEM 
1ypz:C   (ASP198) to   (TRP274)  IMMUNE RECEPTOR  |   H2-T22 PROTEIN, BETA-2-MICROGLOBULIN, T CELL RECEPTOR DELTA, T-CELL RECEPTOR GAMMA CHAIN, IMMUNE SYSTEM 
1ypz:E   (THR135) to   (HIS200)  IMMUNE RECEPTOR  |   H2-T22 PROTEIN, BETA-2-MICROGLOBULIN, T CELL RECEPTOR DELTA, T-CELL RECEPTOR GAMMA CHAIN, IMMUNE SYSTEM 
1n5a:B    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
1n5a:E    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
1n5a:H    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
1n5a:K    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB, B2-MICROGLOBULIN, AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV  |   MURINE MHC, VIRAL ESCAPE, LCMV, IMMUNODOMINANT EPITOPE, IMMUNE SYSTEM 
4pj5:C   (ALA197) to   (GLN268)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR  |   MR1, MAIT TCR, AC-6-FP, IMMUNE COMPLEX, IMMUNE SYSTEM 
4pja:C   (VAL195) to   (GLN268)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
5djc:A   (ASN361) to   (LEU443)  FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
3l9r:A   (GLY200) to   (HIS278)  CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS  |   ANTIGEN PRESENTATION, CATTLE, CD1, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I 
3l9r:B    (LEU23) to    (LYS93)  CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS  |   ANTIGEN PRESENTATION, CATTLE, CD1, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I 
3l9r:C   (ARG201) to   (HIS278)  CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS  |   ANTIGEN PRESENTATION, CATTLE, CD1, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I 
3l9r:E   (GLY200) to   (HIS278)  CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS  |   ANTIGEN PRESENTATION, CATTLE, CD1, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I 
3l9r:F    (LEU23) to    (LYS93)  CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS  |   ANTIGEN PRESENTATION, CATTLE, CD1, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I 
3l9r:H    (LEU23) to    (LYS93)  CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS  |   ANTIGEN PRESENTATION, CATTLE, CD1, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I 
4prp:A   (GLU198) to   (TRP274)  CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4qgt:B   (ASN361) to   (LEU443)  THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON  |   IGG1, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, IMMUNE SYSTEM 
5fkp:A   (HIS203) to   (TRP279)  CRYSTAL STRUCTURE OF THE MOUSE CD1D IN COMPLEX WITH THE P99 PEPTIDE  |   IMMUNE SYSTEM, CD1D, ANTIGEN PRESENTATION, ALPHA-HELICAL 
3ch1:B    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100  |   MHC, H-2DB, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, MELANIN BIOSYNTHESIS, IMMUNE SYSTEM 
3ch1:E    (ASN21) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100  |   MHC, H-2DB, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, MELANIN BIOSYNTHESIS, IMMUNE SYSTEM 
3ch1:H    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100  |   MHC, H-2DB, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, MELANIN BIOSYNTHESIS, IMMUNE SYSTEM 
3ch1:K    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100  |   MHC, H-2DB, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, MELANIN BIOSYNTHESIS, IMMUNE SYSTEM 
3p4n:E    (PRO20) to    (TYR94)  CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM, AN 8-MER PEPTIDE FROM PV  |   H2-KB, PV, LCMV, TCR, T CELL, MHC, VIRAL ESCAPE, IMMUNE SYSTEM 
3qul:K    (ASN21) to    (TYR94)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)  |   MURINE MHC, LCMV, RECEPTOR BINDING, BETA2-MICROGLOBULIN, IMMUNE SYSTEM, T CELL RECOGNITION, T CELL RECEPTOR, CELL SURFACE 
5kzc:E   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01  |   HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM